Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Epivax
Business Services · Rhode Island, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
188 Valley St Ste 424, Providence, Rhode...Phone Number
(401) 272-2123Website
www.epivax.comRevenue
$7.4 MillionIndustry
About Epivax
EpiVax is an American biotechnology firm headquartered in Providence, Rhode Island that specialises in immunoinformatics and immunogenicity risk assessment to support vaccine and biologic drug development. The company uses advanced computational and laboratory methods to help partners optimise therapeutic safety and efficacy and mitigate immune response risks. It collaborates with pharmaceutical companies, regulatory agencies and academic institutions to improve global health outcomes.EpiVax is viewed as a leader in computational immunology, providing critical tools for vaccine design and biologics safety. Industry observers highlight its integration of AI-driven predictions with laboratory validation, which helps pharmaceutical partners accelerate development while reducing immunogenicity-related risks.Explore more
Epivax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Epivax
Compare insights from companies similar to Epivax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Epivax Tech Stack
A closer look at the technologies used by Epivax
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epivax
Sign Up For FreeTo access detailed company insights
EpiVax is an American biotechnology firm headquartered in Providence, Rhode Island that specialises in immunoinformatics and immunogenicity risk assessment to support vaccine and biologic drug development. The company uses advanced computational and laboratory methods to help partners optimise therapeutic safety and efficacy and mitigate immune res... Read More
